Anuh Pharma Q4 FY 2025-26 Investor Presentation Surfaces on BSE
Anuh Pharma has released its Q4 FY 2025-26 investor presentation, providing stakeholders with a detailed overview of the company's recent performance and strategic positioning.
Read article